Amy C. Burrows

Amy C. Burrows

Auto-generated profile, based on publicly available information

Amy C. Burrows

Department of Microbial Science in Health, Cleveland Clinic Research, Cleveland, OH 44195, USA; Microbial Sequencing & Analytics Core Facility, Cleveland Clinic Research, Cleveland, OH 44195, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JSJayasri Das Sarma
Jayasri Das Sarma
ABAmy Burrows
Amy Burrows
PRPatricia Rayman
Patricia Rayman
MHMi-Hyun Hwang
Mi-Hyun Hwang
SKSoumya Kundu
Soumya Kundu
GSGanes Sen
Ganes Sen
The interferon-induced tetratricopeptide repeat protein (Ifit2) protects mice from lethal neurotropic viruses. Neurotropic coronavirus MHV-RSA59 infection of Ifit2-/- mice caused pronounced morbidity and mortality accompanied by rampant virus replication and spread throughout the brain. In spite of the higher virus load, induction of many cytokines and chemokines in the brains of infected Ifit2-/- mice were similar to that in wild-type mice. In contrast, infected Ifit2-/- mice revealed significantly impaired microglial activation as well as reduced recruitment of NK1.1 T cells and CD4 T cells to the brain, possibly contributing to the lack of viral clearance. These two deficiencies were associated with a lower level of microglial expression of CX3CR1, the receptor of the CX3CL1 (Fractalkine) chemokine, which plays a critical role in both microglial activation and leukocyte recruitment. The above results uncovered a new potential role of an interferon-induced protein in immune protection.

1 October 2004 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
JKJoseph E. Kerschner
Joseph E. Kerschner
TMTanya K. Meyer
Tanya K. Meyer
ABAmy Burrows
Amy Burrows
Otitis media is the most common diagnosis in children who visit physicians for illness in the United States,1 causing an estimated 5 million annual episodes at a national cost of $3 billion to $6 billion.2 Approximately 5% to 10% of acute otitis media progresses to chronic otitis media with effusion, which is a leading cause of hearing loss in children. The most accepted treatment of chronic otitis media with effusion is tympanostomy tube insertion, which is now the most frequent pediatric surgical procedure requiring a general anesthetic.1

10 September 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BSBenjamin R. Stromberg
Benjamin R. Stromberg
MSMayank Singh
Mayank Singh
ATAdrian E. Torres
Adrian E. Torres
ABAmy C. Burrows
Amy C. Burrows
DPDebjani Pal
Debjani Pal
MSMatthew Summers
Matthew Summers
The deubiquitinating enzyme USP37 is known to contribute to timely onset of S phase and progression of mitosis. However, it is not clear if USP37 is required beyond S-phase entry despite expression and activity of USP37 peaking within S phase. We have utilized flow cytometry and microscopy to analyze populations of replicating cells labeled with thymidine analogs and monitored mitotic entry in synchronized cells to determine that USP37-depleted cells exhibited altered S-phase kinetics. Further analysis revealed that cells depleted of USP37 harbored increased levels of the replication stress and DNA damage markers γH2AX and 53BP1 in response to perturbed replication. Depletion of USP37 also reduced cellular proliferation and led to increased sensitivity to agents that induce replication stress. Underlying the increased sensitivity, we found that the checkpoint kinase 1 is destabilized in the absence of USP37, attenuating its function. We further demonstrated that USP37 deubiquitinates checkpoint kinase 1, promoting its stability. Together, our results establish that USP37 is required beyond S-phase entry to promote the efficiency and fidelity of replication. These data further define the role of USP37 in the regulation of cell proliferation and contribute to an evolving understanding of USP37 as a multifaceted regulator of genome stability.

28 September 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
WMWilliam Joseph Massey
William Joseph Massey
KKKristen E. Kay
Kristen E. Kay
TJThomas C. Jaramillo
Thomas C. Jaramillo
AHAnthony J. Horak
Anthony J. Horak
SCShijie Cao
Shijie Cao
JBJ. Mark Brown
J. Mark Brown
Microbes living in the intestine can regulate key signaling processes in the central nervous system that directly impact brain health. This gut-brain signaling axis is partially mediated by microbe-host-dependent immune regulation, gut-innervating neuronal communication, and endocrine-like small molecule metabolites that originate from bacteria to ultimately cross the blood-brain barrier. Given the mounting evidence of gut-brain crosstalk, a new therapeutic approach of "psychobiotics" has emerged, whereby strategies designed to primarily modify the gut microbiome have been shown to improve mental health or slow neurodegenerative diseases. Diet is one of the most powerful determinants of gut microbiome community structure, and dietary habits are associated with brain health and disease. Recently, the metaorganismal (i.e., diet-microbe-host) trimethylamine N-oxide (TMAO) pathway has been linked to the development of several brain diseases including Alzheimer's, Parkinson's, and ischemic stroke. However, it is poorly understood how metaorganismal TMAO production influences brain function under normal physiological conditions. To address this, here we have reduced TMAO levels by inhibiting gut microbe-driven choline conversion to trimethylamine (TMA), and then performed comprehensive behavioral phenotyping in mice. Unexpectedly, we find that TMAO is particularly enriched in the murine olfactory bulb, and when TMAO production is blunted at the level of bacterial choline TMA lyase (CutC/D), olfactory perception is altered. Taken together, our studies demonstrate a previously underappreciated role for the TMAO pathway in olfactory-related behaviors.

15 March 2023 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
DKDongkyun Kim
Dongkyun Kim
NRNagendra Kumar Rai
Nagendra Kumar Rai
ABAmy Burrows
Amy Burrows
SKSohee Kim
Sohee Kim
ATAjai Tripathi
Ajai Tripathi
BMBooki Min
Booki Min
Besides antiviral functions, type I IFN expresses potent anti-inflammatory properties and is being widely used to treat certain autoimmune conditions, such as multiple sclerosis. In a murine model of multiple sclerosis, experimental autoimmune encephalomyelitis, administration of IFN-β effectively attenuates the disease development. However, the precise mechanisms underlying IFN-β–mediated treatment remain elusive. In this study, we report that IFN-induced protein with tetratricopeptide repeats 2 (Ifit2), a type I and type III IFN-stimulated gene, plays a previously unrecognized immune-regulatory role during autoimmune neuroinflammation. Mice deficient in Ifit2 displayed greater susceptibility to experimental autoimmune encephalomyelitis and escalated immune cell infiltration in the CNS. Ifit2 deficiency was also associated with microglial activation and increased myeloid cell infiltration. We also observed that myelin debris clearance and the subsequent remyelination were substantially impaired in Ifit2−/− CNS tissues. Clearing myelin debris is an important function of the reparative-type myeloid cell subset to promote remyelination. Indeed, we observed that bone marrow–derived macrophages, CNS-infiltrating myeloid cells, and microglia from Ifit2−/− mice express cytokine and metabolic genes associated with proinflammatory-type myeloid cell subsets. Taken together, our findings uncover a novel regulatory function of Ifit2 in autoimmune inflammation in part by modulating myeloid cell function and metabolic activity.

9 July 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
IZIrina Zhevlakova
Irina Zhevlakova
IMIuliia Molokotina
Iuliia Molokotina
ABAmy C. Burrows
Amy C. Burrows
AHAnthony J. Horak
Anthony J. Horak
NSNaseer Sangwan
Naseer Sangwan
Tatiana V. ByzovaTatiana V. Byzova
Tatiana V. Byzova